Jesse Ledger
Corporate Officer/Principal bei Canadian Healthcare Licensing Association
Aktive Positionen von Jesse Ledger
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Canadian Healthcare Licensing Association | Corporate Officer/Principal | - | - |
Karriereverlauf von Jesse Ledger
Ehemalige bekannte Positionen von Jesse Ledger
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TRIBUTE PHARMACEUTICALS CANADA INC | Corporate Officer/Principal | - | - |
SteriMax, Inc.
SteriMax, Inc. Pharmaceuticals: MajorHealth Technology SteriMax, Inc. provides pharmaceutical products and services. The firm specializes in the development, production, marketing and distribution of essential hospital and retail pharmacy products to the Canadian healthcare market. Its products include BaciJect, Bupivacaine Injection BP, ceFAZolin for Injection, and AcetaZOLAMIDE for Injection USP. The company was founded by Mahen J. Acharya and is headquartered in Oakville, Canada. | Corporate Officer/Principal | - | - |
NUVO PHARMACEUTICALS INC. | Vorstandsvorsitzender | 01.11.2017 | - |
Corporate Officer/Principal | 06.04.2016 | 16.11.2016 | |
Präsident | 16.11.2016 | - |
Ausbildung von Jesse Ledger
Trent University | Undergraduate Degree |
Statistik
International
Kanada | 6 |
Operativ
Corporate Officer/Principal | 4 |
Chief Executive Officer | 1 |
President | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
Aralez Pharmaceuticals Canada, Inc.
Aralez Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Aralez Pharmaceuticals Canada, Inc. operates as a pharmaceutical company which focuses on the acquisition, licensing, development, and promotion of healthcare products. It also sells Uracyst and NeoVisc internationally through a number of strategic partnerships. The company was founded by Peter Roy Riehl and Robert Paul Harris on November 14, 1994 and is headquartered in Mississauga, Canada. | Health Technology |
Nuvo Pharmaceuticals, Inc.
Nuvo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through the following segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. The Commercial Business segment includes Blexten, Cambia, the canadian business for Resultz and Suvexx, and mature assets. The Production and Service Business segment supplies Pennsaid to Horizon for the U.S. market and is engaged in ongoing partnering efforts for Pennsaid. The Licensing and Royalty Business segment engages in the selling of Vimovo. The company was founded on August 22, 1983 and is headquartered in Mississauga, Canada. | Health Technology |
Canadian Healthcare Licensing Association | |
SteriMax, Inc.
SteriMax, Inc. Pharmaceuticals: MajorHealth Technology SteriMax, Inc. provides pharmaceutical products and services. The firm specializes in the development, production, marketing and distribution of essential hospital and retail pharmacy products to the Canadian healthcare market. Its products include BaciJect, Bupivacaine Injection BP, ceFAZolin for Injection, and AcetaZOLAMIDE for Injection USP. The company was founded by Mahen J. Acharya and is headquartered in Oakville, Canada. | Health Technology |
- Börse
- Insiders
- Jesse Ledger
- Erfahrung